BioCentury
ARTICLE | Financial News

Antares adds $50 million

October 4, 2012 12:59 AM UTC

Drug delivery company Antares Pharma Inc. (NASDAQ:ATRS) raised $50 million through the sale of 12.5 million shares at $4 in a follow-on underwritten by Jeffries; Oppenheimer; Cowen; and Ladenburg Thal...